Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure

Shuhei Tanaka1, Teruhiko Imamura1, Nikhil Narang2

  • 1Second Department of Internal Medicine, University of Toyama, Japan.

Insights

Percutaneous closure is a safe and effective treatment for secundum atrial septal defects (ASDs) in both children and adults. This minimally invasive approach offers comparable success rates to surgical repair, making it a preferred option for many patients.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Interventional Cardiology

Background:

  • Atrial septal defects (ASDs) are common congenital heart disorders.
  • Percutaneous closure is a widely adopted, minimally invasive alternative to surgical repair for secundum ASDs.
  • Treatment decisions require careful consideration of patient comorbidities and defect characteristics.

Purpose of the Study:

  • To review the current approaches to percutaneous closure of secundum atrial septal defects.
  • To highlight the factors influencing the choice between percutaneous and surgical closure.
  • To emphasize the importance of echocardiography in management planning.

Main Methods:

  • Review of current literature and clinical guidelines on percutaneous ASD closure.
  • Assessment of patient comorbidities (pulmonary hypertension, arrhythmias, diastolic dysfunction).
  • Evaluation of anatomical features and defect types via echocardiography.

Main Results:

  • Percutaneous ASD closure demonstrates non-inferiority to surgical repair in both pediatric and adult populations.
  • Echocardiography is crucial for tailoring management strategies based on defect morphology.
  • Patient comorbidities significantly influence the selection of closure technique.

Conclusions:

  • Percutaneous closure is a highly effective and less invasive option for secundum ASDs.
  • Individualized patient assessment, including comorbidities and anatomical details, is essential for optimal outcomes.
  • Minimally invasive percutaneous techniques are increasingly preferred for ASD management.

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
105
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
109
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
171
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
95
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
123
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
122